Innovation Pharmaceuticals Inc (IPIX)

[Ultimate01]

http://www.neogenomics.com/Collateral/Images/English-US/NeoTYPE-Lung-Sample-Report-092214.pdf

Ok, this may not be significant to most but it is to me. I have found what I believe to be 3rd party verification/endorsement that Kevetrin activates and restores P-53 function.

This report is from a specialized lab providing a pathology report of sorts for a male patient with lung cancer born in 1950.

Specimen date(s)

Collection Date: 7/25/2014 12:00:00 AM
Received Date: 7/31/2014 3:45:00 PM
Report Date: 8/7/2014 4:05:36 PM

I am NOT a physician but my opinion is based on the following quote listed multiple times on this report:

"Additionally, kevetrin (thioureidobutyronitrile) is a novel drug that activates p53 and may be effective in treatment of drug-resistant cancers with mutant p53. Phase 1 clinical trials are underway with this compound
(Kumar et al., 2012; AACR 2012, Abstract 2874)."

I am pumped up but I realize that this may be of little to no significance.

BK, SLICIMMUNO, TOB or any other knowledgeable posters care to share their opinion?